Bright liver, body composition and insulin resistance changes with nutritional intervention: a follow‐up study
- 5 September 2008
- journal article
- clinical trial
- Published by Wiley in Liver International
- Vol. 28 (9) , 1280-1287
Abstract
Background: Nonalcoholic fatty liver disease (NAFLD) because of its association with obesity, diabetes and insulin resistance (IR), is the hepatic expression of metabolic syndrome. Exercise and nutritional intervention can improve and prevent these inter‐related conditions; the relationships between the degree of IR and ultrasound (US) morphological post‐interventional changes are not defined.Aims: The aim of our study was to assess the relationship, if any, in NAFLD patients, among IR, BMI and degree of bright liver, before and after 6 months of a moderately hypocaloric/balanced dietary/lifestyle treatment. Fifty outpatients with a clinical and US diagnosis of NAFLD were studied.Methods: Liver echogenicity [Bright Liver Score (BLS)] was scored on a four‐graded scale. IR was assessed by homoeostasis model‐insulin resistance (HOMA‐IR). Body composition was assessed by bioimpedance assessment and skinfold measurements.Results: A significant decrease of BLS was observed, with a concurrent decrease of body weight, body mass index (BMI) and HOMA‐IR. Bright liver decrease has a trend parallel to IR, much less steep than the trend of bright liver reduction against US liver dimensions, body weight and BMI decrease. HOMA‐IR is the only baseline variable that enters significantly in the multiple regression and, alone, explains 21.4% of variance in predicting bright liver degree. After dietary interventions, both HOMA‐IR and BMI are significantly involved in the multiple regression and explain, together, 42.3% of variance in predicting bright liver degree; variation in BLS can be predicted by variation of body weight and of US longitudinal measurement of the liver.Conclusions: Liver US BLS appears to be a useful tool, both alone and along with other US measurements and body weight changes, for the assessment of clinical‐metabolic amelioration in patients treated with dietetic interventions. The clinical‐diagnostic role, if any, of other assessed laboratory analyses, in the subset of NAFLD, does not appear to be definite.Keywords
This publication has 21 references indexed in Scilit:
- The role of bright liver echo pattern on ultrasound B-mode examination in the diagnosis of liver steatosisDigestive and Liver Disease, 2006
- Bedside Ultrasound Can Predict Nonalcoholic Fatty Liver Disease in the Hands of Clinicians Using a Prototype ImageDigestive Diseases and Sciences, 2006
- Insulin resistance and clinical aspects of non-alcoholic steatohepatitis (NASH)Hepatology Research, 2005
- Effects of Diet and Exercise on Muscle and Liver Intracellular Lipid Contents and Insulin Sensitivity in Type 2 Diabetic PatientsThe Journal of Clinical Endocrinology & Metabolism, 2005
- A Randomized Controlled Trial of Metformin versus Vitamin E or Prescriptive Diet in Nonalcoholic Fatty Liver DiseaseAmerican Journal of Gastroenterology, 2005
- Low–Grade Steatosis and Major Changes in Portal Flow As New Prognostic Factors in Steroid–Treated Alcoholic HepatitisHepatology, 2004
- Modest weight loss and physical activity in overweight patients with chronic liver disease results in sustained improvements in alanine aminotransferase, fasting insulin, and quality of lifeGut, 2004
- Effect of the volume and intensity of exercise training on insulin sensitivityJournal of Applied Physiology, 2004
- Comparison of liver histology with ultrasonography in assessing diffuse parenchymal liver diseaseClinical Radiology, 1991
- Ultrasound scanning in the detection of hepatic fibrosis and steatosis.BMJ, 1986